|The AmeriKat nestling in for an|
intellectual evening of Top 10 of 2011
In the course of 2011 the IPKat received around 800,000 views from 325,000 individual visitors from over 200 countries (compared to 100,000 fewer views and visitors in 2010) –- not counting the Kat's 6,200-plus subscribers. The past year was full of events and milestones in the field of intellectual property, but what were the Kat’s readers' top stories of 2011? The AmeriKat analyzed the Kat's analytics and has compiled a list of the Kat's most-read stories of 2011 for your viewing pleasure; she has listed them bottom-upwards, starting with the tenth most-read story and culminating with the top one. Happy 2012!
|A replica Stormtrooper helmet,|
perfect for braving the New England
|His Honor Judge Birss QC|
The CJEU gave guidance as to the definitional ambit of “human embryo”. A “human embryo” includes any human ovum after fertilization, any non-fertilized human into which the cell nucleus from a mature human cell has been transplanted and any non-fertilized human ovum whose division and further development have been stimulated by parthenogenesis, i.e. if a cell(s) is not capable of subsequent development into a human being it is not a “human embryo” . However, the Court declined to rule on whether pluripotent stem cells obtained at the blastocyst stage were “human embryos”. Instead the CJEU held that it was a question for the referring court to ascertain whether pluripotent stem cells obtained from a human embryo at the blastocyst stage were capable of commencing the process of development of a human being and thus excluded under the definition of “human embryo”. Although the usual concerns about the CJEU meddling in moral and definitional matters that should be left to Member States were raised, it was the Court’s decision on the second referred question which held that there should be no distinction between the use of embryos for scientific research and use for purely commercial processes that caused the most comments on the Kat’s posting. The controversial decision is also subject to UCL IBIL’s February event with an excellent panel of speakers including the IPKat's friend Dr. Justin Turner QC.
|Perhaps one of the few headlines not protectable...|